Influence of Intravenous Iron Therapy on Novel Markers of Iron Deficiency

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Artificial Organs

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/039139881003300505PMID 20593351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A primer on iron therapy.

  2007cited by this paper
• Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.

  2007cited by this paper
• Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients

  2007cited by this paper
• Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation.

  2007cited by this paper
• Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states

  2006cited by this paper
• Assessing iron status: beyond serum ferritin and transferrin saturation.

  2006cited by this paper
• Comparison of the Automated Reticulocyte Counts and Immature Reticulocyte Fraction Measurements Obtained With the ABX Pentra 120 Retic Blood Analyzer and the Sysmex XE-2100 Automated Hematology Analyzer

  2001cited by this paper
• The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.

  2001cited by this paper
• New Red Cell Parameters on the Sysmex XE-2100TM as Potential Markers of Functional Iron Deficiency

  2001cited by this paper
• A randomized trial of iron deficiency testing strategies in hemodialysis patients.

  2001cited by this paper
• European best practice guidelines 1-4: evaluating anaemia and initiating treatment.

  2000cited by this paper
• Hypochromic red blood cells and reticulocytes.

  1999cited by this paper
• Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts.

  1999cited by this paper
• Response of mean reticulocyte haemoglobin content to intravenous iron therapy in haemodialysis patients.

  1998cited by this paper
• Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis.

  1998cited by this paper
• Reticulocyte indices in patients with end stage renal disease on hemodialysis.

  1998cited by this paper
• Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.

  1997cited by this paper
• Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.

  1994cited by this paper
• Reticulocyte quantification by flow cytometry, image analysis, and manual counting.

  1992cited by this paper
• Iron balance in hemodialysis patients.

  1977cited by this paper
• QUANTITATING IRON BALANCE IN HEMODIALYSIS PATIENTS

  1977cited by this paper
• Quantitating iron balance in hemodialysis patients.

  1977cited by this paper

• Anemia in Peritoneal Dialysis Patients; Iron Repletion, Current and Future Therapies

  2017cites this paper
• Efficacy and Safety of Intravenous Iron Therapy for Functional Iron Deficiency Anemia in Hemodialysis Patients: A Meta-Analysis

  2014cites this paper
• Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease

  2012cites this paper
• Iron therapy in patients with chronic kidney disease

  2012cites this paper
• Ich denk' es war ein gutes Jahr* (Reinhard Mey, 1968)--the year 2010 balance.

  2010cites this paper
• Ich Denk’ es War Ein Gutes Jahr * (Reinhard Mey, 1968) – The year 2010 Balance

  2010cites this paper